摘要
目的探究晚期非小细胞肺癌患者应用伽马刀联合复方红豆杉胶囊的治疗效果。方法 60例晚期非小细胞肺癌患者作为研究对象,采取随机数字表法将患者分为观察组与对照组,各30例。对照组患者接受伽马刀治疗,观察组患者进行伽马刀联合复方红豆杉胶囊治疗。对比两组患者的疗效、不良反应、生活质量,随访2年,观察两组患者的生存率。结果观察组患者治疗总有效率为96.67%,高于对照组的80.00%,差异具有统计学意义(P<0.05)。观察组患者的不良反应率与对照组比较,差异均无统计学意义(P>0.05)。观察组患者生活质量评分均高于对照组,差异均具有统计学意义(P<0.05)。观察组患者2年生存率为100.00%,高于对照组的86.67%,差异具有统计学意义(P<0.05)。结论晚期非小细胞肺癌患者应用伽马刀联合复方红豆杉胶囊的治疗效果良好,患者2年生存率高,生活质量佳,值得推广应用。
Objective To investigate the treatment effect of advanced non-small cell lung cancer patients treated with gamma knife combined with compound Hongdoushan capsules. Methods A total of 60 advanced non-small cell lung cancer patients as study subjects were divided by random number table method into observation group and control group, with 30 cases in each group. The control group was treated with gamma knife, and the observation group was treated with gamma knife and compound Hongdoushan capsules. Comparison were made on efficacy, adverse reactions, quality of life between two groups, and 2 year survival rate in two groups was observed. Results The observation group had higher total treatment effective rate as 96.67% than 80.00% in the control group, and the difference was statistically significant （P〈0.05）. The observation group had no statistically significant difference in incidence of adverse reactions comparing with the control group （P〉0.05）. The observation group had higher quality of life score than the control group, and the difference was statistically significant （P〈0.05）. The observation group had higher 2 year survival rate as 100.00% than 86.67% in the control group, and the difference was statistically significant （P〈0.05）. Conclusion Combination of gamma knife and compound Hongdoushan capsules provides excellent treatment effect for advanced non-small cell lung cancer patients, with higher 2 year survival rate and better quality of life. It is worthy of promotion and application.
出处
《中国实用医药》
2017年第30期4-6,共3页
China Practical Medicine
关键词
晚期非小细胞肺癌
伽马刀
复方红豆杉胶囊
2年生存率
Advanced non-small cell lung cancer
Gamma knife
Compound Hongdoushan capsules
2 year survival rate
